Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2001

View Archived Issues

Agile Therapeutics to evaluate once-weekly contraceptive patch in phase II trials

Zonagen's lead SPRM shows potential in treatment of endometriosis

Pipeline and program update provided by Texas Biotechnology

N-Acetylcysteine deserves further evaluation in Crohn's disease according to pilot study

CancerVax therapeutic vaccine significantly increases survival in late-stage cancers

Biota acquires NuMAX

Pharmacia's Vestra deemed not approvable by FDA

NitroMed's NO-donating proton pump inhibitors proven superior to lansoprazole in ulcer models

Promising preliminary results reported for AGI-1067 in postangioplasty restenosis

TAK-637, a selective, nonpeptide NK1 antagonist for IBS

Cambridge Antibody Technology reviews product pipeline

ETA antagonist delays disease progression, improves quality of life in late-stage prostate cancer

Company Profile: ALviva

Interim results of two Revimid studies presented at Myeloma Workshop

Vertex ICE inhibitor may have promise in inflammatory and autoimmune skin diseases

Preclinical studies support further testing of noscapine in malignant melanoma

Interferon Sciences licenses novel approach for prevention of tumor recurrence

ATS 2001: AWD-12-281 has beneficial effects on mucus secretion and lung neutrophilia

New research broadens understanding of mechanism of action for SAANDs

Obesity-related gene, methods for diagnosis and treatment of obesity, disclosed in recent patent

Adhesion receptor antagonists reported by Merck as useful in thrombotic disorders

Potential antidepressants in the GSK pipeline

Synthesis and use of azepinoindole PARP inhibitors in neurodegenerative disorders

Antiischemic adenosine agonists designed by Pfizer

Two patents issued for Lilly's new serotonergic piperidine derivatives

GlycoDesign and Leo select antithrombotic drug candidates

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026